LifeMD (LFMD) Payables (2012 - 2025)

LifeMD has reported Payables for 14 years, with the latest figure at $14.9 million in Q4 2025.

• For the quarter ending Q4 2025, Payables rose 27.78% year-over-year to $14.9 million; the trailing twelve-month figure through Dec 2025 stood at $14.9 million (up 27.78% YoY), and the FY2025 full-year result was $14.9 million, up 27.78% from the prior year.
• Payables for Q4 2025 stood at $14.9 million, down from $20.3 million in the prior quarter.
• The five-year high for Payables was $325.4 million in Q3 2023, with the low at $9.5 million in Q1 2023.
• Historically, Payables has averaged $30.0 million across 5 years, with a median of $13.7 million in 2021.
• Annual changes were most pronounced in 2023 — Payables jumped 2711.57% — and 2024, when it plunged 94.89%.
• LifeMD's Payables stood at $10.0 million in 2021, then climbed by 8.9% to $10.9 million in 2022, then grew by 12.0% to $12.2 million in 2023, then retreated by 4.17% to $11.7 million in 2024, then advanced by 27.78% to $14.9 million in 2025.
• The last three Payables figures came in at $14.9 million (Q4 2025), $20.3 million (Q3 2025), and $25.1 million (Q2 2025), per Business Quant data.